Advertisement

Related Videos

Peter Clark, MA, MD, FRCP: A Payer Perspective

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Daniel Goldstein, MD: Interventional Pharmacoeconomics - Why and How

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

Opening Session Panel Discussion

Advertisement

Advertisement




Apr
20
Today In Oncology
Melanoma Can AI Enable Diagnosis Prediction
AI Tool Shows Early Ability in Pinpointing Cells Driving Aggressive Cancers
DRUP Trial Investigates Use of Off-Label Drugs for Patients With Advanced Solid Tumors
Sequential or Concurrent Radiotherapy and Immunotherapy in Advanced Newly Diagnosed or Refractory NSCLC
Romiplostim for Chemotherapy-Induced Thrombocytopenia
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo